Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,384 public trials 840 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Not Yet Recruiting

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

NCT06614751

Conditions: Advanced Cancer, BRCA Mutation, Breast Cancer, +44 more
Locations: Peking University Cancer Hospital and Institute Beijing, Beijing Municipality, China

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijjing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis.

NCT06585735

Conditions: Chronic Disease, Chronic Pancreatitis, Digestive System Diseases, +9 more
Locations: Asian Institute of Gastroenterology Hospitals Hyderabad, Telangana, India

View Trial Details

Not Yet Recruiting

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

NCT06573398

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

NCT06571461

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions

NCT06563232

Conditions: Abdominal Neoplasm, Excluding Pancreas Neoplasm, Abdominal Neoplasms, Digestive System Diseases, +12 more
Locations: Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

NCT06531291

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +15 more
Locations: Renji hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

NCT06276803

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Research of the Application of Artificial Intelligence Model "PANDA"

NCT06528223

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: the First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

the First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

NCT06513455

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures

NCT06495749

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease, +9 more
Locations: First Affiliated Hospital, Medical College of Zhejiang University Hangzhou, Zhejiang, China

the First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Pancreatic Diseases

Pancreatic Diseases trial results

Related conditions